Title : Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.

Pub. Date : 2013 Feb

PMID : 23469683






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway. acadesine TSC complex subunit 2 Homo sapiens
2 The combination of AICAR and ATO produced a synergistic effect in the treatment of HL-60 cells involving AMPK/TSC2/mTOR pathway, and AICAR reduced ATO-mediated apoptotic death on acute promyelocytic leukemia NB4 cells. acadesine TSC complex subunit 2 Homo sapiens